Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome

European Heart Journal

Volumn 32, Issue 11, 2011, Pages 1390-1397

  Nazer, Babak ^a   Ray, Kausik K ^b   Sloan, Sarah ^a   Scirica, Benjamin ^a   Morrow, David A ^a   Cannon, Christopher P ^a   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Biomarkers; Heart failure; Prognosis

Indexed keywords

ATORVASTATIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; NEOPTERIN; PRAVASTATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; POST HOC ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEPTANOIC ACIDS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; PRAVASTATIN; PROPORTIONAL HAZARDS MODELS; PYRROLES; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 79958145754     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr032     Document Type: Article

References (26)

1. Sharma R, Coats AJ, Anker SD. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J of Cardiol 2000;72: 175-186. (Pubitemid 30068636)
2. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;223:236-241. (Pubitemid 20225044)
3. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-a and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93:704-711.
4. Finkel MS, Oddis CV, Jakob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 157:387-389.
5. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman ML, Mann DL. Tumor necrosis factor-a provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997;95:1247-1252. (Pubitemid 27097837)
6. Scirica BM, Morrow DA, Cannon CP, de Lemos JA, Murphy S, Sabatine MS, Wiviott SD, Rifai N, McCabe CH, Braunwald E. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin Chem 2007;53: 1800-1807.
7. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 2006;47:962-968.
8. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003;52:313-321. (Pubitemid 36995156)
9. Gieseg SP, Crone EM, Flavall EA, Amit Z. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/ 7,8-dihydroneopterin synthesis. Br J Pharmacol 2008;153:627-635. (Pubitemid 351271748)
10. Ray KK, Morrow DA, Sabatine MS, Shui A, Rifai N, Cannon CP, Braunwald E. Long term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndromes. Circulation 2007;115: 3071-3078.
11. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. New Engl J Med 2004;350: 1495-1504. (Pubitemid 38477774)
12. Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the TIMI-22 PROVE IT trial. J Am Coll Cardiol 2005;46:1417-1424. (Pubitemid 41446175)
13. Scirica BM, Morrow DA, Cannon CP, Ray KK, Sabatine MS, Jarolim P, Shui A, McCabe CH, Braunwald E. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. J Am Coll Cardiol 2006;47:2326-2331.
14. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172. (Pubitemid 351193639)
15. Garcia-Moll X, Cole D, Zouridakis E, Kaski JC. Increased serum neopterin: a marker of coronary artery disease activity in women. Heart 2000;83:346-350. (Pubitemid 30313342)
16. Schumacher M, Halwachs G, Tatzber F, Fruhwald FM, Zweiker R, Watzinger N, Eber B, Wilders-Truschnig M, Esterbauer H, Klein W. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997;30: 703-707. (Pubitemid 27397650)
17. Auer J, Berent R, Labetanig E, Eber B. Serum neopterin and activity of coronary artery disease. Heart Dis 2001;3:297-301. (Pubitemid 33136297)
18. Estévez-Loureiro R, Recio-Mayoral A, Sieira-Rodríguez-Moret JA, Trallero-Araguás E, Kaski JC. Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis 2009;207:514-518.
19. Trachtenberg BH, Hare JM. Biomarkers of oxidative stress in heart failure. Heart Fail Clin 2009;5:561-577.
20. Panas D, Khadour FH, Szabó C, Schulz R. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. Am J Physiol 1998; 275:1016-1023.
21. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 2000;87: 241-247. (Pubitemid 30626433)
22. Widner B, Baier-Bitterlich G, Wede I, Wirleitner B, Fuchs D. Neopterin derivatives modulate the nitration of tyrosine by peroxynitrite. Biochem Biophys Res Commun 1998;248:341-346. (Pubitemid 28386423)
23. Balogh A, Mittermayr M, Schlager A, Balogh D, Schobersberger W, Fuchs D, Margreiter J. Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart. Biochim Biophys Acta 2005;1724:17-22. (Pubitemid 40799107)
24. Werner ER, Bichler A, Daxenbichler G, Fuchs D, Fuith LC, Hausen A, Hetzel H, Reibnegger G, Wachter H. Determination of neopterin in serum and urine. Clin Chem 1987;33:62-66. (Pubitemid 17104095)
25. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001;26:319-329. (Pubitemid 32989554)
26. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Insights from a cohort of 12.065 patients with new-onset heart failure. Circulation 2003;107:223-225. (Pubitemid 36135214)